Biotivia has signed an agreement to collaborate with Dr. Roberto Gambari, head of the Thalasemmia Lab at the University of Ferrara, to test the ability of Transmax to induce fetal hemaglobin cells in Thalasemmia patients. In vitro studies have shown a remarkable ability of Transmax to induce new red blood cells in the blood of human patients. This is highly significant as the alternative these sufferers have is a lifetime of whole blood transfusions and costly highly toxic pharmaceuticals.

Biotivia Company Categories

Biotivia Company Extra

Biotivia Links
Discount Club
Biotivia Blog

© Copyright 2012 Biotivia LLC, 1 River Place, Suite 1001, New York, NY 10036. All rights reserved. These statements have not been evaluated by the Food and Drug Administration.
Products are not intended to diagnose, treat, cure, or prevent any disease. BIO as it appears on this site and on many of Biotivia's products is not meant to imply that a product is certified Organic pursuant to the rules of the US, The EU or any other national or international organisation. BIO is an integral part of our trademarked name and the names of some of our products. It is not intended, nor do we believe it conveys this impression, to cause confusion with the internationally recognized BIO certification symbol.